BPC-157 vs KPV
Updated · Educational, not medical advice
The short answer
Both are asked about for gut symptoms. BPC-157 is a 15-amino-acid peptide from a stomach-protein fragment; KPV is a three-amino-acid fragment of alpha-MSH studied for inflammation. Evidence for both is mainly from animal and lab studies, neither is FDA-approved, and both were recommended for compounding by an FDA advisory committee in July 2026, pending FDA action.
Side by side
Questions
What is the difference between BPC-157 and KPV?
Both are asked about for gut symptoms. BPC-157 is a 15-amino-acid peptide from a stomach-protein fragment; KPV is a three-amino-acid fragment of alpha-MSH studied for inflammation. Evidence for both is mainly from animal and lab studies, neither is FDA-approved, and both were recommended for compounding by an FDA advisory committee in July 2026, pending FDA action.
Can you take BPC-157 and KPV together?
Some clinicians prescribe them together; the combination has not been studied in controlled trials.
Do I need a prescription for BPC-157 or KPV?
Yes. Both should be prescribed by a licensed clinician and prepared by a licensed pharmacy. Avoid products sold as "research use only".
Sources
- PubMed: published research on BPC-157
- ClinicalTrials.gov: registered studies of BPC-157
- AJMC: FDA panel backs 6 peptides for compounding (July 31, 2026)
- Health Affairs Forefront: the advisory committee's peptide vote
- World Anti-Doping Agency: Prohibited List
- PubMed: published research on KPV peptide